Αρχική World News News digest – targeted radiation beam, precision medicine and our early detection...

News digest – targeted radiation beam, precision medicine and our early detection roadmap

We’re challenging researchers to tackle 9 of the toughest cancer problems

We’ve partnered with the National Cancer Institute (NCI) in our most ambitious research initiative ever. Cancer Grand Challenges aims to bring scientists together to solve problems like, ‘how do some cells stay normal despite have mistakes in their DNA?’ and ‘why do some cancers return many years after treatment?’ Read all about the 9 challenges on our blog

Targeted radiation beams help cancer patients swallow 

A new technique has been developed to help reduce a common side effect of radiotherapy for people with throat cancer. Currently, around 3 in 4 people with this type of cancer are left with lifelong swallowing issues due to radiotherapy causing irreparable damage to healthy tissue and muscle surrounding the tumour. The new, more accurate radiotherapy technique could help around 12,000 people a year in the UK. Full story at The Daily Mail.

Pushing to detect cancer earlier 

Currently, just over half of all cancer cases are detected at the earliest stages. Our new roadmap outlines how researchers, pharmaceutical companies and governments can work together to build a future where no-one gets a late stage cancer diagnosis on our blog.

New precision treatment approach for pancreatic cancer  

Researchers from the University of Glasgow are developing new ways to predict who could benefit from treatments targeting damaged DNA in pancreatic cancer, reports The Scotsman. The study, which is linked to our Precision Panc platform used cells from people with pancreatic cancer to develop new molecular markers than can predict who will respond to which drug. Clinical trials using this strategy are set to begin shortly, as our news report explains.

Confusion over COVID and lung cancer symptoms 

Experts fear that many people experiencing cancer symptoms aren’t talking to their GP, as cases of COVID-19 increase across the country. Lung cancer is a particular area of concern, with experts worried that people may mistake possible lung cancer symptoms for the virus. Symptoms of lung cancer can include a cough that doesn’t go away after 2-3 weeks, breathlessness and lack of energy. BBC and The Guardian reveal more. 

Taming the cell cycle

Researchers at the our Manchester Institute have developed a new approach to synchronise the cell division cycle of an entire population of human cells in the lab. Read our researcher features article about how this technique could help cell biologists study cancer in more detail.

And finally

Campaigner Patrick McGuire has written an open letter to Boris Johnson about honouring his manifesto commitments in the upcoming Comprehensive Spending Review. Read our blog post to hear from more of our campaigners on why the Government must uphold its promises, including to increase cancer survival rates and boost early cancer diagnosis.  

Scarlett Sangster is a writer for PA Media Group

More on this topic

Source

NEWSLETTER

Συμπληρώστε το email σας για να λαμβάνετε τις σημαντικότερες ειδήσεις από το ogkologos.com

Βρείτε μας

2,449ΥποστηρικτέςΚάντε Like
57ΑκόλουθοιΑκολουθήστε

Διαβαστε Επίσης

ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ)

ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ) Γράφει ο Δρ Παπαδούρης Σάββας, Παθόλογος-Ογκολόγος   Ο ΜΜΚΠ βρίσκεται αναλογικά στο 80% και πλέον του συνολικού...

Διατρέχουν όντως οι καρκινοπαθείς μεγαλύτερο κίνδυνο λόγω κοροναϊού;

Σε πρακτικό επίπεδο, τα δεδομένα των σχετικών μελετών υποδηλώνουν ότι η χημειοθεραπεία ή οι άλλες αντι-νεοπλασματικές θεραπείες δεν αυξάνουν σημαντικά τον κίνδυνο θνησιμότητας από...

FDA: Η ακτινοβολία των smartphones δεν προκαλεί καρκίνο

Σε μια νέα έκθεσή της, η Υπηρεσία Τροφίμων και Φαρμάκων (FDA) των ΗΠΑ αναφέρει ότι επανεξέτασε τις σχετικές επιστημονικές έρευνες που δημοσιεύθηκαν τα τελευταία...

Νέα ανακάλυψη, νέα ελπίδα για τον καρκίνο

Ένα νεοανακαλυφθέν τμήμα του ανοσοποιητικού μας συστήματος θα μπορούσε να αξιοποιηθεί για την αντιμετώπιση όλων των ειδών καρκίνου, σύμφωνα με επιστήμονες του πανεπιστημίου Cardiff...

Καρκίνος: Ευεργετική για τους καρκινοπαθείς η άσκηση

Σημαντικά ωφέλη προσφέρει η άσκηση, ακόμη και σε ασθενείς με καρκίνο. Οι περισσότεροι ασθενείς αγνοούν τα οφέλη που μπορεί να έχει γι’ αυτούς η συχνή...

Prostate Cancer

The article is provided by Scientific Communications Officer of NIPD Genetics, Ms Marina Charitou (MSc) Prostate Cancer Awareness Prostate cancer is the second most common cancer...
- Advertisment -

Ροή Ειδήσεων

News digest – ovarian cancer blood test, statins, spending review and head and neck cancer immunotherapy

Ovarian cancer blood test ‘better than previously thought’   A new investigation into an existing blood test to detect ovarian cancer has uncovered better-than-expected...

Woman with Nonverbal Autism Diagnosed with Breast Cancer After Caregiver Sister Finds Lump

Tabitha Cyrus, whose friends and family affectionately call her Taffy, was three years old when she was diagnosed with autism. Her family had anticipated...

Living With Metastatic Breast Cancer: How I Reinvented Myself

Shonte Drakeford is a 36-year-old Washington, D.C. native, nurse practitioner, United States Army wife, and German Shepherd mama. She was diagnosed with stage IV...

The Mediterranean Diet

The Mediterranean diet is a predominately plant based diet that accents omega 3 rich fish sources and whole foods that are minimally processed. Olives...

Results of Continuous vs Intermittent Dosing Schedules of BRAF/MEK Inhibitor Combination Therapy in the S1320 Study

Opposite to the initial study hypothesis, the results of the S1320 indicate that intermittent dosing of BRAF/MEK inhibitor combination did not improve progression-free survival...

FDA Approves Companion Diagnostic to Identify NTRK Fusions in Solid Tumours for Larotrectinib

On 23 October 2020, the US Food and Drug Administration (FDA) approved the next-generation sequencing (NGS)-based FoundationOne CDx test (Foundation Medicine, Inc.) as a...